Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation. - sprookjes - yvandenbroek - TriplyDB

Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation.

Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation.

http://www.wikidata.org/entity/Q33498360

about

Risk factors for celiac disease Structural and Functional Studies of trans -Encoded HLA-DQ2.3 (DQA1*03:01/DQB1*02:01) Protein Molecule Th17, intestinal microbiota and the abnormal immune response in the pathogenesis of celiac disease Stabilizing mutations increase secretion of functional soluble TCR-Ig fusion proteins.Celiac disease: how complicated can it get?On the perils of poor editing: regulation of peptide loading by HLA-DQ and H2-A molecules associated with celiac disease and type 1 diabetes.Pathophysiology of celiac disease Celiac disease and autoimmune-associated conditions.HLA and celiac disease susceptibility: new genetic factors bring open questions about the HLA influence and gene-dosage effects.Assessing of Celiac Disease and Nonceliac Gluten Sensitivity Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires Trans heterodimer between two non-arthritis-associated HLA alleles can predispose to arthritis in humanized mice The HLA-DQ2 genotype selects for early intestinal microbiota composition in infants at high risk of developing coeliac disease.Gut microbes and adverse food reactions: Focus on gluten related disorders High Frequency of Haplotype HLA-DQ7 in Celiac Disease Patients from South Italy: Retrospective Evaluation of 5,535 Subjects at Risk of Celiac Disease.Nomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ molecules.Celiac disease and transglutaminase 2: a model for posttranslational modification of antigens and HLA association in the pathogenesis of autoimmune disorders.HLA-DQA1 and HLA-DQB1 in Celiac disease predisposition: practical implications of the HLA molecular typing The promised land of human immunology Dietary gluten triggers concomitant activation of CD4+ and CD8+ αβ T cells and γδ T cells in celiac disease Presence of DQ2.2 Associated with DQ2.5 Increases the Risk for Celiac Disease.Exploring T cell reactivity to gliadin in young children with newly diagnosed celiac disease.On the future of HLA.The adaptive immune response in celiac disease.Refractory celiac disease: from bench to bedside.Coeliac disease and rheumatoid arthritis: similar mechanisms, different antigens.CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytes Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation.T Cells in Celiac Disease.The roles of MHC class II genes and post-translational modification in celiac disease.HLA-A*31 as a marker of genetic susceptibility to sepsis.A TCRα framework-centered codon shapes a biased T cell repertoire through direct MHC and CDR3β interactions.An insertion mutant in DQA1*0501 restores susceptibility to HLA-DM: implications for disease associations.Interleukin-21-mediated TLR4 activation in celiac disease.The role of HLA DQ2 and DQ8 in dissecting celiac-like disease in common variable immunodeficiency.A quarter of patients with type 1 diabetes have co-existing non-islet autoimmunity; the findings of a UK population-based family study.Human leukocyte antigen typing using buccal swabs as accurate and non-invasive substitute for venipuncture in children at risk for celiac disease.Characterizing the binding motifs of 11 common human HLA-DP and HLA-DQ molecules using NNAlign.HLA variation and disease.HLA-DQ2 and -DQ8 genotype frequency in Syrian celiac disease children: HLA-DQ relative risks evaluation.

P2860

Q26798375-5941A908-6957-40B2-AA96-A32DFCB98D6A Q27677454-079E256D-7393-4D9D-8E75-857268C33026 Q28082659-EC661D74-7ACA-46BB-8639-348634344D2F Q33671435-2797BBD2-19F7-4133-9E28-55B9929EDDF5 Q34128112-89B373D4-CFE5-46E3-976D-C75CB14D121A Q34150236-8B338830-D2A2-4B09-B6A6-F21B53F52E5D Q34307239-6268F566-29CE-4EF5-A3D4-4A34D582D2B2 Q34367160-B15B6254-BA4C-45AF-B319-0516F957B5D4 Q34465035-2D9299AC-59C1-41A3-B6ED-6858EE9FF473 Q34480252-F26343FF-8B35-4246-9D17-BB217F35AEC8 Q34978613-F63265A5-F3D1-41F6-8D3A-7AD7E5ED3754 Q35019501-5A6E8926-B7A1-4215-ADA1-D5642AA63587 Q35190089-F9061826-E95C-48B6-9226-E4892F77E4BF Q35498128-332B39E2-AA2A-42D3-8E78-36A60E79FE99 Q35785234-70328B71-21CB-4883-87A9-009F17468D22 Q35951955-11B069F5-0212-4816-B78A-51113AA9DB1C Q36190939-5C8B688A-0498-45EE-B633-518B242A081A Q36351049-6C8A51A8-A23D-4FB4-97BA-8BAF1AD0CA48 Q36978245-EFD2550F-43D7-40E1-B700-B0410A4A9B6F Q37088595-2AC0876E-2598-4B41-BFDF-8C727891751C Q37500752-1B23E1EE-10E6-4DDF-BDDA-4EC0EDFBED34 Q37645021-A51DB614-418A-4E7D-AF10-CABF12E5A44F Q37935058-A173E36B-5F70-4B37-9E73-C77E1586E87C Q38005620-425D3655-A1E9-4241-AA50-9E2F4BC6CEC7 Q38027424-1CD65719-59A6-4366-8399-A855CA3378F4 Q38489669-3FD1AF01-49C1-4199-A1C4-DE97442C70E4 Q39042122-8645E571-C9B5-4B81-9D97-58BEFE3B4B81 Q39214326-37647078-A3D1-4BA1-A015-D840AE6BA425 Q39217707-CAB220F7-818E-40AC-88C2-EFE977056725 Q39427548-0CC29480-00FD-4626-975B-2EDF5FC1E9D7 Q39894355-EDB65D7A-627E-4B9B-9A3C-416E737FC69A Q40063793-1A5847D5-A125-4296-BFB9-82F736BD2633 Q42873027-13F0761D-B7A2-4E0E-A3E3-71899086F345 Q43460332-244B8E6D-44A8-4757-8E25-6DA76D9BE9D8 Q45154317-4CB22A6D-32C1-430F-8970-7153B4916E17 Q50065306-8AD25D7C-A3E2-434A-A564-2FA811DBC27A Q50558991-55DFF2BB-5E6D-45DE-BD97-83217F99EC50 Q51419330-3EEC3D22-C336-4462-A32B-6A7CF562D9F6 Q52732932-F75E4292-F28C-4C0E-B291-81C13E024373 Q55177414-3533A402-EC31-4DD1-91F6-80E306024C4D

P2860

Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation.

http://www.wikidata.org/entity/Q33498360

description

2009 nî lūn-bûn

@nan

2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Differences in the risk of cel ...... d gluten antigen presentation.

@ast

Differences in the risk of cel ...... d gluten antigen presentation.

@en

type

label

Differences in the risk of cel ...... d gluten antigen presentation.

@ast

Differences in the risk of cel ...... d gluten antigen presentation.

@en

prefLabel

Differences in the risk of cel ...... d gluten antigen presentation.

@ast

Differences in the risk of cel ...... d gluten antigen presentation.

@en

P1433

Q33498360-85D6E567-1143-4B28-8576-3ACBB9499661

P1476

Q33498360-46FBA932-1990-444A-83B9-740DF90D141F

P2093

Q33498360-3F2A2F61-2233-4BC5-BCE0-4F91173C184C

Q33498360-7C59FB0B-E083-4F41-9663-68A5683583EA

Q33498360-AD0A4372-27C6-4C38-BCE4-03973CA2663D

Q33498360-B79821FF-3A77-4909-947D-80E665C4E802

Q33498360-EA3D5AD8-565F-43E6-837A-4E76635DE5A0

P2860

Q33498360-05EB8CC4-1727-4035-9109-16AC7C01DE29

Q33498360-07819231-5C25-41CC-BCAA-6E55C14AE52B

Q33498360-0B11832B-08D1-45E9-BC49-F615908AA377

Q33498360-135B3B43-061A-4CF9-9D01-94F96E7FF9DA

Q33498360-14DF0E59-23D6-4AFE-8E63-DC4510901E69

Q33498360-329A9BA2-1FC9-46EA-B740-91FB2C66A744

Q33498360-3C5AFFD0-FF00-4446-9570-72D0E28713BD

Q33498360-54A3B87C-0B92-45B0-A7E9-7CE694AADE6D

Q33498360-712ED97B-0A3C-460A-8210-710A00B30027

Q33498360-7376B564-A136-4398-87C8-E23E95C04756

P304

Q33498360-B913AA0D-60FE-4BC3-98F6-20B455B99224

P31

Q33498360-8E1809FC-B905-40B7-9965-61A064C7AFB2

P356

Q33498360-5C49B5C5-F3B2-48F6-9610-EB5BE7B8C634

P407

Q33498360-ECD3FDAB-EB03-4C3F-BA02-D0ACA97429B4

P433

Q33498360-D1FED9E7-6CF6-4A5C-8E2F-4C0D9684057F

P478

Q33498360-32081FC3-CF5A-4BF8-A797-5F0428B62E33

P50

Q33498360-B56059C3-437C-4540-A79F-A89B4DCE13F7

P577

Q33498360-E5855602-93A6-4FDD-AA97-02F4132BCEC1

P5875

Q33498360-5C1E1673-32E5-45AF-AB6A-DD4B9B9CAE7D

P698

Q33498360-2B46892A-B448-4062-9312-935547F0154A

P356

P1433

Nature Immunology

P1476

Differences in the risk of cel ...... d gluten antigen presentation.

@en

P2093

Axel Berg-Larsen

http://www.w3.org/2001/XMLSchema#string

Elin Bergseng

http://www.w3.org/2001/XMLSchema#string

Kinya Hotta

http://www.w3.org/2001/XMLSchema#string

Lars-Egil Fallang

http://www.w3.org/2001/XMLSchema#string

Ludvig M Sollid

http://www.w3.org/2001/XMLSchema#string

P2860

Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease

The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses

MolProbity: all-atom contacts and structure validation for proteins and nucleic acids

Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes

Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy

A structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac disease

Probing the Specificity Determinants of Amino Acid Recognition by Arginase † ‡

Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide

Crystal structure of I-Ak in complex with a dominant epitope of lysozyme

UCSF Chimera--a visualization system for exploratory research and analysis

P304

1096-1101

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NI.1780

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-08-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26777788

http://www.w3.org/2001/XMLSchema#string

P698

19718029

http://www.w3.org/2001/XMLSchema#string